Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2017-06-22 Regulatory Filings
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
EVOTEC AG: LAB282 ACCELERATES WITH SECOND ROUND FUNDING
Regulatory Filings Classification · 100% confidence The document is a press release dated June 22, 2017, announcing that the LAB282 drug discovery partnership has awarded funding to five new life sciences projects. It details the nature of the partnership, the projects supported, and includes quotes from executives. This content is a general corporate announcement regarding business activities and strategic partnerships, not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general news announcement about business operations and strategic progress, and does not fit into the more specific categories like Capital/Financing (CAP) or M&A (TAR), the most appropriate classification is the general regulatory announcement/news category, RNS, as it is disseminated via the DGAP service which handles 'Financial/Corporate News and Press Releases'. Given the content is a corporate news item, RNS is the best fit among the provided options, acting as a broad corporate update.
2017-06-22 English
EVOTEC ANNOUNCES STRATEGIC INVESTMENT IN FACIO THERAPIES TO SUPPORT DEVELOPMENT OF NOVEL FSHD THERAPY
Regulatory Filings Classification · 99% confidence The document is a press release titled "EVOTEC ANNOUNCES STRATEGIC INVESTMENT IN FACIO THERAPIES TO SUPPORT DEVELOPMENT OF NOVEL FSHD THERAPY". It details a corporate action (strategic investment and partnership expansion) rather than presenting periodic financial results (like 10-K or IR), management compensation (DEF 14A), or voting outcomes (DVA). It is an announcement about a business development/financing activity. While it mentions an investment, it is not a general capital raise announcement (CAP) but a specific strategic partnership/investment. Since it describes a corporate event that is not explicitly covered by other codes (like M&A, DIV, ER, etc.), and it is a formal news release disseminated via DGAP, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous corporate news announcements that don't fit the highly specific financial reporting codes. Given the content is a strategic business update, RNS is the most appropriate general classification.
2017-06-20 English
RESOLUTIONS OF THE ANNUAL GENERAL MEETING 2017 OF EVOTEC AG
AGM Information Classification · 99% confidence The document explicitly states in the title and content that it contains the 'RESOLUTIONS OF THE ANNUAL GENERAL MEETING 2017 OF EVOTEC AG'. It details the outcomes of shareholder votes, including the approval of agenda items, election of a new board member, and approval of capital/remuneration systems. This content directly corresponds to the information typically released following an AGM, specifically focusing on the results and resolutions passed. The most appropriate code is AGM-R (AGM Information). Although it contains voting results (DVA), the primary context is the overall meeting summary and resolutions, making AGM-R a better fit than DVA, which is usually just the vote tally.
2017-06-14 English
EVOTEC JOINS NURTURE CONSORTIUM TO MINE UNIQUE KIDNEY DISEASE PATIENT BIOBANK
Regulatory Filings Classification · 100% confidence The document is a press release dated June 14, 2017, announcing that Evotec AG has joined the NURTuRE consortium to work on kidney disease drug discovery. It contains key highlights, quotes from management, and background information about the consortium and the disease area. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed interim report (IR). It is a general corporate announcement regarding a strategic partnership/research initiative. Since it is a news announcement about corporate activity that doesn't fit the specific categories like M&A (TAR) or Capital Change (CAP), the most appropriate classification is the general Regulatory Filings/News category, RNS, as it is disseminated via DGAP (a service for regulatory announcements and corporate news). Given the content is a news announcement about a partnership, RNS is the best fit among the available options.
2017-06-14 English
Evotec Hauptversammlung 2017
AGM Information Classification · 99% confidence The document text is titled 'Evotec Hauptversammlung 2017' (Evotec Annual General Meeting 2017) and contains an 'Agenda' which includes sections like 'Begrüßung und Vorstellung' (Welcome and Introduction), 'Shifting: Paradigmenwechsel für innovationseffiziente Translation' (Shifting: Paradigm Shift for Innovation-Efficient Translation), 'Finanzen – Rückblick & Ausblick' (Finance - Review & Outlook), and sections dedicated to the Supervisory Board ('Aufsichtsrat') and Management Board ('Vorstand'). The content structure, including the agenda format and the explicit mention of the 'Hauptversammlung' (General Meeting), strongly indicates that this document is presentation material used during the Annual General Meeting. This aligns perfectly with the definition for AGM Information (AGM-R). It is not a formal regulatory filing like a 10-K, nor is it a short announcement (RPA/RNS) given its substantial length and detailed content.
2017-06-14 German
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in voting rights percentages (3.32%) held by JPMorgan Asset Management (UK) Limited in Evotec AG, crossing or reaching a threshold on May 17, 2017. This directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema.
2017-05-31 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.